您当前的位置:
首页 >
文章列表页 >
Modified Sanpiantang Treats Nitroglycerin-induced Migraine in Rats via p38 MAPK/iNOS Signaling Pathway
更新时间:2023-10-20
    • Modified Sanpiantang Treats Nitroglycerin-induced Migraine in Rats via p38 MAPK/iNOS Signaling Pathway

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 29, Issue 22, Pages: 64-70(2023)
    • DOI:10.13422/j.cnki.syfjx.20231339    

      CLC: R2-0;R33;R747.2;R289
    • Published:20 November 2023

      Published Online:18 September 2023

      Received:04 July 2023

    扫 描 看 全 文

  • WANG Kun,MA Ming,YANG Yanhua,et al.Modified Sanpiantang Treats Nitroglycerin-induced Migraine in Rats via p38 MAPK/iNOS Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):64-70. DOI: 10.13422/j.cnki.syfjx.20231339.

  •  
  •  

0

Views

19

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Comprehensive Clinical Evaluation of Duliang Soft Capsules in Treatment of Migraine with Wind-cold Blood Stasis Syndrome
Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler
Mechanism of Mahuang Xixin Fuzitang Against Migraine Based on Network Pharmacology and Experimental Validation
Modified Sanpiantang in Treatment of Migraine: A Review

Related Author

ZHAO Xiaoxiao
ZHANG Xuming
XI Junyu
LU Zhenkai
LIU Fumei
WANG Lianxin
LI Yuanyuan
XIE Yanming

Related Institution

Graduate School, Tianjin University of Traditional Chinese Medicine
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Graduate School of Anhui University of Chinese Medicine
The First Afffiliated Hospital of Anhui University of Chinese Medicine
Dongfang Hospital,Beijing University of Chinese Medicine
0